Actively Recruiting
Remotely Observed Methadone Evaluation II
Led by Sonara Health · Updated on 2026-03-27
100
Participants Needed
1
Research Sites
122 weeks
Total Duration
On this page
Sponsors
S
Sonara Health
Lead Sponsor
C
Chestnut Health Systems
Collaborating Sponsor
AI-Summary
What this Trial Is About
Methadone is an effective treatment for severe opioid use disorder (OUD), but access is limited due to the requirement of daily observed dosing by most opioid treatment programs (OTPs). Sonara Health designed a HIPAA-compliant web-application called Sonara that features integrated video dosing recording, a tamper-evident seal, and an innovative measurement-based care (MBC) framework called the Opioid Craving Visual Analogue Scale (OC-VAS) to facilitate methadone take-homes while providing evidence of appropriate use and monitoring patient outcomes. Phase II of this SBIR aims to compare Sonara against usual take-homes to assess its impact on retention in care, opioid use, patient outcomes, and costs of care.
CONDITIONS
Official Title
Remotely Observed Methadone Evaluation II
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Willing to participate in a randomized trial
- Able to complete study instruments and interviews
You will not qualify if you...
- Less than 18 years of age
- Pregnant or planning to be pregnant
- Currently involved in the criminal justice system
- Serious mental health problems
- Treated with buprenorphine
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
FGC Wabash
Chicago, Illinois, United States, 75220
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here